From "I feel fine" to knowing for sure — in as little as 7 days.

Adults with known plaque, risk factors, or a family history of heart disease — people who want to prevent heart attacks and strokes proactively instead of reacting after the fact. It fits patients who value data, deep testing and continuous adjustment, and who are ready to work with a medical team on both medication and lifestyle.

It is not for anyone with active chest pain, severe shortness of breath or a suspected heart attack — call 911 or go to the nearest emergency room. It is also not a fit for people who want a one-off scan with no follow-up, who are looking for the cheapest insurance-based option, or who are not willing to consider treatment and lifestyle changes along with ongoing monitoring. Certain conditions — severe kidney disease or a serious contrast allergy, for example — can make a CCTA inappropriate; we review that with you on your call.

We currently see patients in Dallas, TX; New York City, NY; Miami Beach, FL; and Scottsdale, AZ. We are expanding with new locations roughly every three months, including a commitment to open two California locations by the end of 2026.

Because the care is personalized, so is the investment. On your assessment call we review your history, risks and goals, determine the level of testing and support that makes sense for you, and then present your options and pricing. You are not buying a scan — you are joining a medically supervised prevention program. Most patients should plan on a minimum investment of $5,000.

No. ClearCardio is a cash-pay, premium, out-of-network program. Insurance is designed to pay for late-stage disease and procedures, not for deep prevention. Many patients use HSA or FSA funds, or submit our invoices for possible out-of-network reimbursement — but we do not bill insurance directly.

A CCTA (coronary CT angiography) is a CT scan of the heart using contrast dye, so we can look directly at your coronary arteries: how much plaque is there, where it sits, what type it is (soft vs. calcified), plus any narrowing and the overall health of the artery. Instead of estimating from risk factors, it lets us see disease while it is still silent.

A CCTA is the better tool for seeing coronary plaque and narrowing, because contrast makes the artery itself visible. A non-contrast calcium score CT shows only calcified plaque and misses the soft, rupture-prone plaque. Cardiac MRI is excellent for structure, function and scar, but it is not the primary tool for coronary plaque.

A calcium score only sees hardened (calcified) plaque. The soft, rupture-prone plaque that drives most heart attacks is invisible to it. A zero score lowers risk but does not rule out disease — the CCTA sees both plaque types inside the artery wall.

An EKG records electrical activity — it does not see plaque. A stress test usually turns abnormal only once a blockage is already significant. An echocardiogram shows structure and function, but does not map plaque. A catheterization is invasive and is used for high suspicion or for a procedure, not as preventive plaque screening.

"Slice" refers to how many image slices the scanner captures per rotation. A 64-slice is older, standard technology: it often needs several rotations, which can mean more motion artifact, potentially more radiation and a higher chance of misinterpretation. A 640-slice can capture the heart in a single rotation — clearer images, a shorter exam, and the potential for excellent image quality at a lower radiation dose with the right protocols.

Yes — for appropriate candidates the scan is considered safe. The 640-slice CCTA uses a fraction of the radiation of older CT scanners, the protocol is optimized per patient, and Dr. Osborne's team reviews whether imaging is appropriate for you before anything is scheduled.

Not necessarily. We have more than 150 tools available, and a statin is only one option among them. Before any medication is recommended we look at your plaque (CCTA plus AI analysis), your lipids and advanced labs, inflammation, genetics and other biological factors, and your overall risk profile and preferences. Every plan is discussed in detail, so you understand the reasoning behind it.

That's exactly what the program is for. You'll get a personalized treatment plan — medication, lipids, nutrition, sleep, stress and inflammation — plus ongoing follow-up and repeat testing through the Proof Program to verify whether the plan is working.

That is personalized. The timing of imaging follow-up depends on your initial findings, your risk level and your treatment plan. For many patients it means periodic follow-up imaging to confirm whether plaque is stabilizing or regressing, coordinated with the Proof Program and clinical judgment. We explain the schedule — and the reasoning behind it — before you commit.

Most patients have real answers in as little as 7 days from their first consultation — including a personally-read scan and a treatment plan session with the team.

Many patients travel for imaging and for the key in-person visits, then continue virtually. On your call we go over travel logistics, which visits need to be onsite, and how much of the program runs through telemedicine and remote monitoring.

Yes. We do not replace emergency, hospital or primary care. We coordinate with your physicians and share reports and plans with them.

Yes — cardiac CT scans are increasingly available elsewhere. But the scan is just the tool: what matters is what's being measured, who's reading it, and what they do next. Relatively few physicians specialize in high-resolution CCTA interpretation — and fewer still integrate AI analysis, genetic risk, lipid profiling and treatment protocols into one personalized plan. The scan matters, but so does the expertise behind it.

Most cardiologists are trained to intervene after symptoms appear — catheterizations, stents, bypass surgery — not to detect disease early. Very few U.S. cardiologists hold additional board certifications in lipidology and hypertension, and advanced CCTA interpretation is a specialized skill relatively few physicians pursue. Your doctor may mean well and still be using tools that can't see soft plaque.

Yes. We operate under HIPAA with BAA-supported scheduling and storage systems. Your data is never sold or shared for marketing.